Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Leadership Changes at Synaptics CFO Resigns New Principal Accounting Officer Named

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Technology Cloud computing Trading online
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Synaptics announced on February 27, 2024, that its CFO, Dean Butler, has resigned with immediate effect. Butler will remain in an advisory role until April 5, 2024, to support the company during the transition. Esther Song, a seasoned employee with 16 years of experience at Synaptics, has been named the new Principal Accounting Officer while retaining her positions as Vice President and Corporate Controller. In another development, Kermit Nolan, who retired as Chief Accounting Officer in 2023, is returning as a consultant to offer guidance to the internal team.

Synaptics Inc. (SYNA) Stock Sees Positive Trend with Increase in Share Price

On February 27, 2024, Synaptics Inc. (SYNA) saw a positive trend in its stock performance, with the price of its shares increasing by $0.38 since the market last closed. This represents a 0.37% rise from the previous closing price of $104.32. However, in pre-market trading, the stock has dropped by $1.32.

SYNA is currently trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the long term and is showing positive momentum. Investors may see this as a bullish sign for the company’s future prospects.

Synaptics Inc. (SYNA) Stock Performance Analysis: Revenue Decline but Improved Net Income and EPS

On February 27, 2024, Synaptics Inc. (SYNA) stock had a mixed performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $1.35 billion for the past year, which represented a 22.11% decrease compared to the previous year. However, the total revenue remained flat at $237.00 million for the most recent quarter. Synaptics reported a net income of $73.60 million for the past year, marking a significant 71.42% decrease from the previous year. The net income for the most recent quarter showed an improvement, with a net loss of -$9.00 million, representing an 83.81% increase compared to the previous quarter. Earnings per share (EPS) for Synaptics also experienced a decline over the past year, with a reported EPS of $1.83, a 71.06% decrease from the previous year. However, there was a notable improvement in EPS for the most recent quarter, with a reported EPS of -$0.23, representing an 83.98% increase compared to the previous quarter. Investors and analysts will likely continue to monitor the company’s financial performance and market trends to assess the future potential of SYNA stock.

Tags: SYNA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Chatham Lodging Trust Exceeds Q1 2024 Financial Projections

Perrigo Reports Strong Earnings Growth in Fourth Quarter 2024

Wind Farms: How Strategic Acquisitions Amplify the Impact of Green Energy Players

Analyzing Atlas Energy Solutions Q4 2023 Financial Results

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com